— Perrigo Company plc (NYSE: PRGO) reported Q3 2019 earnings of $1.04 per share, vs. $0.93 expected.
— Sales grew 5.1% to $1.2 billion, vs. $1.2 billion expected.
— Worldwide Consumer net sales increased 3.3% to $961 million.
— Prescription Pharmaceuticals sales improved 13.6% to $230 million.
— FY19 GAAP EPS is expected to be $2.01-2.21.
— FY19 adjusted EPS is expected to be $3.85-4.05.
— PRGO shares gained 0.98% following the announcement.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
QCOM Earnings: Qualcomm Q2 2024 revenue and profit beat Street view
Semiconductor company Qualcomm, Inc. (NASDAQ: QCOM) reported an increase in earnings and revenues for the second quarter of 2024. The numbers came in above analysts' estimates. At $9.39 billion, March-quarter
Key takeaways from Amazon’s Q1 2024 earnings report
Amazon.com Inc. (NASDAQ: AMZN) had an upbeat start to fiscal 2024, delivering strong growth across the business in the first three months of the year. While the cloud segment continues
Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report
Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results. Although the top and bottom line numbers decreased
